17 November 2026 - Canadian pharmaceutical company Apotex Health Corp (TSX:APTX) announced on Monday the US launch of Axitinib Tablets, 1 mg and 5 mg, the first generic version of Pfizer's INLYTA, a kinase inhibitor indicated for the treatment o...
17 November 2026 - Biotechnology company Rakuten Medical Inc announced on Monday that it has initiated a Phase 1 clinical trial of RM-0256 photoimmunotherapy in Japan.RM-0256, an anti-PD-L1 antibody-light-activatable dye conjugate, is the third drug ...
17 November 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) said on Tuesday that its Japanese partner Eisai Co Ltd (TYO:4523) has presented new five-year data from the Clarity AD study and its long-term extension, showing in...
17 November 2026 - Chinese pharmaceutical company Akeso Inc (HKEX:9926) announced on Monday that China's National Medical Products Administration (NMPA) has accepted its supplemental New Drug Application (sNDA) for ivonescimab in combination wit...
17 November 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) said on Monday that Alexion, AstraZeneca Rare Disease's Klygefa (gefurulimab) has been approved in both the US and the European Union for adults with an...